# Bayer OY – FDA Inspection, Jun 1, 2018

Source: https://www.keypedia.com/records/fda_inspections/bayer-oy/eb270355-f562-4afe-a57d-a5516d1fec89
Source feed: FDA_Inspections

> FDA inspection 1055914 of Bayer OY, June 01, 2018. Classification: Voluntary Action Indicated (VAI). Form 483 issued. 5 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1055914
- Company Name: Bayer OY
- Inspection Date: 2018-06-01
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1273226 - 2023-09-15
- [FDA Inspection 972548 - 2016-04-15](https://www.keypedia.com/records/fda_inspections/bayer-oy/7019f2e3-295a-4049-9a2e-24deef3e9305)
- FDA Inspection 803182 - 2012-10-02
- FDA Inspection 762223 - 2011-12-15
- FDA Inspection 694779 - 2010-09-24

## Related Officers

- [Jose A. Cruz Gonzalez](https://www.keypedia.com/people/jose-a-cruz-gonzalez/a005cff1-0a90-4396-82c4-de4b0a579374)

Company: https://www.keypedia.com/companies/bayer-oy/6b66b42c-5aa1-47a0-b486-f49aa5b33a68

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c